Leading the Respondent
Leading the Respondent: Can the background information and the format of the choice sets impact responses to a discrete choice experiment?
Leading the Respondent: Can the background information and the format of the choice sets impact responses to a discrete choice experiment?
The EuHEA seminar series brings together health economists all across its member associations, and beyond, to discuss cutting-edge research.
Thursday June 9th, 2022; 7AM EDT/ 12PM BST/ 2PM EAT/ 7PM CST & AWST/ 9PM AEST The Teaching Health Economics Special Interest Group (THE SIG) has organized a series of virtual workshops during 2022. The first workshop provided an overview of curriculum development and writing powerful learning outcomes for health economics courses. If you missed this workshop, […]
The COVID-19 pandemic has exacerbated existing inequalities and given rise to new ones. Tackling health and economic inequalities in the post-pandemic United Kingdom effectively will require policies based on solid evidence. The purpose of this symposium is to provide a multi-disciplinary forum focusing on effective ways to ‘level up’, from what is known to evidence […]
The EuHEA seminar series brings together health economists all across its member associations, and beyond, to discuss cutting-edge research. Wednesdays, 2:30-3:30pm (CET), starting from February 23 until June 15.
The 100th Health Economists' Study Group (HESG) meeting will be hosted by ScHARR HEDS on Wednesday, June 22nd to Friday, June 24th, 2022, at the Best Western Plus The Quays Hotel in Sheffield. Further details including conference fees can be found on the conference webpage here, which is updated regularly. HESG Conference Planning Committee Email: hesg-summer-2022@sheffield.ac.uk. Twitter: @HESG2022Shef.
The Teaching Health Economics Special Interest Group (THE SIG) has organized a series of virtual workshops during 2022. The first workshop provided an overview of curriculum development and writing powerful learning outcomes for health economics courses. If you missed this workshop, you can view the presentations here. Details for the next upcoming virtual workshops are provided […]
Presenter: John Buckell, University of Oxford Objectives: To compare the impacts of providing brief advice (A), brief advice plus individually-tailored shopping advice (A+S) or taxation (T) and combinations thereof, on the amount of saturated fat (SFA) in consumers shopping baskets relative to control. Methods: Econometric analysis and simulation using data from a randomized controlled […]
The WHO & UNFPA, Sexual and Reproductive Health and Universal Health Coverage, Learning by Sharing Portal (SRH-UHC LSP) has been under development since April 2020. The LSP profiles national-level implementation stories on advancing access to quality and comprehensive sexual and reproductive as an integral component of wider UHC strategies and processes. Objectives: 1. Officially launch […]
Moderator: David Bishai Panelists: Damian Walker, Zina Jarrah, Tessa Tan Torres Suppose you already have compelling evidence that something works and is good value for money, how should that evidence be packaged and presented? What evidence matters to whom? This panel discussion will help participants make a better investment case for a health policy decision. […]
Genomic medicine is rapidly changing the healthcare paradigm for multiple conditions, including cancer and rare diseases. With governments around the world increasingly investing in genomics research and implementation into clinical practice, and with the health economics evidence base on genomic medicine expanding, it is important to reflect on the role of health economics to change […]
Presenter: Ann Livingstone, University of Sydney Ann was recently awarded her PhD. She has a keen interest in patient preferences in trial-based and modelled economic evaluation. In addition, she works as an evaluator for the Australian Medical Services Advisory Committee, reviewing and critiquing evidence to inform government policy decision-making regarding health technologies. Adjuvant immunotherapy has […]